Novelix Pharmaceuticals Ltd vs Zydus Lifesciences Ltd
A side-by-side comparison of Novelix Pharmaceuticals Ltd (NOVELIX) and Zydus Lifesciences Ltd (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Zydus Lifesciences Ltd leads NOVELIX vs ZYDUSLIFE on 10 of 14 metrics (1 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
Valuation
How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free.", "Promoter holding has increased by 4.86% over last quarter.", "Company's median sales growth is 42.1% of last 10 years", "Company's working capital requirements have reduced from 222 days to 122 days"]
- − ["Stock is trading at 3.01 times its book value", "Though the company is reporting repeated profits, it is not paying out dividend", "Company has a low return on equity of 5.12% over last 3 years.", "Company has high debtors of 163 days.", "Promoter holding has decreased over last 3 years: -12.6%"]
- + ["Company has delivered good profit growth of 18.8% CAGR over last 5 years"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.